Allopurinol
The active substance of A is allopurinol. Allopurinol belongs to a group of medicines called enzyme inhibitors. These substances are effective in controlling the rate of certain changes in the body.
A is used long-term to prevent gout and may be used in other conditions related to an excess of uric acid in the body, such as kidney stones and other kidney diseases, as well as when the patient is receiving treatment for cancer or has enzyme function disorders.
In case of doubts before taking A, consult a doctor.
Before starting to take A, discuss it with your doctor if:
Particular caution should be exercised when taking A:
The use of A in children is rarely indicated, except for certain cancers (especially leukemia) and certain enzyme disorders, such as Lesch-Nyhan syndrome.
It is especially important to tell your doctor if you are taking any of the following medicines. Your doctor may need to reduce the dose of A and/or monitor you more closely due to the increased risk of side effects when A is taken with the following medicines:
If aluminum hydroxide is taken at the same time, allopurinol may have a weaker effect. A gap of at least 3 hours should be maintained between taking both medicines.
Blood disorders occur more frequently when allopurinol is taken with cytostatics (e.g., cyclophosphamide, doxorubicin, bleomycin, procarbazine, alkyl halides) than when these active substances are taken alone.
Therefore, regular blood morphology tests should be performed.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult a doctor or pharmacist before taking this medicine. Allopurinol is excreted in the breast milk of nursing mothers. The use of allopurinol is not recommended during breastfeeding.
A tablets may cause drowsiness or coordination disorders. If such symptoms occur, do not drive or operate machinery.
If the patient has previously been diagnosed with intolerance to some sugars, they should contact their doctor before taking the medicine.
This medicine should always be taken as directed by your doctor. In case of doubts, consult a doctor.
Method of administration
A should be taken orally, once a day, after a meal, with a glass of water.
The amount of A that can be taken may vary greatly. The doctor will decide on the dose of A that is suitable for the patient.
Recommended dose
Usual doses range from 100 to 300 mg per day. The dose may be increased to 900 mg per day, depending on the severity of the disease.
Doses greater than 300 mg should be given in divided doses, not exceeding 300 mg at a time. The doctor usually starts treatment with a low dose of allopurinol (e.g., 100 mg per day) to reduce the risk of side effects. If necessary, the dose will be increased.
In elderly patients or patients with liver or kidney function disorders, the doctor usually uses a lower dose or recommends longer intervals between doses.
In the case of patients undergoing dialysis two or three times a week, the doctor may recommend taking the medicine in a dose of 300 or 400 mg per day, which is taken immediately after dialysis.
Usual doses range from 100 to 400 mg per day.
In case of taking a higher dose of A than recommended, contact a doctor or go to the hospital immediately. Show the doctor the package with the tablets.
Symptoms of overdose may include nausea, vomiting, diarrhea, and dizziness.
If a dose is missed, take the next scheduled dose as soon as possible.
If it is almost time for the next dose, skip the missed dose.
Do not take a double dose to make up for the missed dose.
Do not stop treatment without consulting a doctor.
In case of any further doubts about the use of this medicine, consult a doctor, nurse, or pharmacist.
Like all medicines, A can cause side effects, although not everybody gets them.
Uncommon(may affect less than 1 in 100 people):
Immediatelycontact a doctor if the patient experiences any of the following symptoms:
Rare(may affect less than 1 in 1,000 people):
Very rare(may affect less than 1 in 10,000 people):
Frequency not known(frequency cannot be estimated from the available data):
THE ABOVE SYMPTOMS MAY INDICATE THAT THE PATIENT IS ALLERGIC TO ALLUPOL. In such cases, DO NOTcontinue treatment, unless the doctor advises otherwise.
Common(may affect less than 1 in 10 people):
Uncommon(may affect less than 1 in 100 people):
Rare(may affect less than 1 in 1,000 people):
Very rare(may affect less than 1 in 10,000 people):
Frequency not known(cannot be estimated from the available data):
If you experience any side effects, including any side effects not listed in this leaflet, tell your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: 22 49-21-301
Fax: 22 49-21-309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep the medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the carton.
The expiry date refers to the last day of the month.
Do not store above 25°C
No special precautions for storage.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
White, round, flat tablets with a dividing line.
The dividing line on the tablet is only to facilitate breaking the tablet to make it easier to swallow and not to divide it into equal doses.
The pack contains 50 tablets and an information leaflet.
White, round, 12 mm in diameter, convex tablets with a dividing line embossed on one side and "300" embossed on the other side.
The tablet can be divided into equal doses.
The medicine is packaged in aluminum/PVC blisters placed in a cardboard box.
The box contains 30 tablets and a patient information leaflet.
GEDEON RICHTER POLSKA Sp. z o.o.
ul. Ks. J. Poniatowskiego 5
05-825 Grodzisk Mazowiecki
phone: +48 (22) 755 50 81
Poland
To obtain more detailed information, contact:
GEDEON RICHTER POLSKA Sp. z o.o.
ul. Ks. J. Poniatowskiego 5
05-825 Grodzisk Mazowiecki
phone: +48 (22) 755 96 48
lekalert@grodzisk.rgnet.org
((marketing authorization holder's logo))
((pharmacode))
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.